Home > Insider Trading > Filing (0001535610-14-000055)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1541157	Celsus Therapeutics Plc.	CLTX	Pharmaceutical Preparations (2834)	981034922

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1433766	Hal Mintz	C/O Sabby Management, Llc 10 Mountainview Road, Suite 205 Upper Saddle River NJ 07458	No	No	Yes	No
1535610	Sabby Management, Llc	10 Mountainview Road Suite 205 Upper Saddle River NJ 07458	No	No	Yes	No
1561018	Sabby Healthcare Volatility Master Fund, Ltd.	C/O Sabby Management, Llc 10 Mountainview Road, Suite 205 Upper Saddle River NJ 07458	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-09	1,075	$5.51	756,430	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2014-04-10	1,400	$5.25	757,830	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2014-04-11	100	$5.15	757,930	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

This Form 4 is being filed by Sabby Healthcare Volatility Master Fund, Ltd. ("SHVMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. The Advisor is the investment manager of SHVMF. Mr. Mintz is the manager of the Advisor.
The amounts reported herein reflect the entire amount of the Issuer's securities held by SHVMF as of each transaction date. Each of the Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed an admission that either the Advisor of Mr, Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.